Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL1BS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,174
Award facts
- Contract value 100% obligated
- $21,173.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,173.92 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-count units) with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary pharmaceutical supply vehicle for military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and veteran healthcare programs. The DLA Troop Support Medical contract vehicle under which this delivery order was issued encompasses pharmaceutical products across multiple therapeutic domains and enables flexible fulfillment of government medical procurement needs on a global scale. This contract award demonstrates the contractor's continued capability to meet federal procurement requirements for essential pharmaceutical commodities through open competition.
Quick answers
Who was awarded contract SPE2DR26FL1BS?
SPE2DR26FL1BS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FL1BS worth?
The government has obligated $21,174 on SPE2DR26FL1BS.
Is contract SPE2DR26FL1BS an order under another contract?
Yes. SPE2DR26FL1BS is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1BS competed?
The extent of competition for SPE2DR26FL1BS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award